Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This change does not modify study details, eligibility criteria, or page functionality.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The older Revision: v3.4.1 entry and the government funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:48:35.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center status was added. The site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T07:56:18.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated QC-related metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or renamed.
    Difference
    0.2%
    Check dated 2026-01-28T05:49:42.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4; prior tag v3.3.3 is no longer displayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:34:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section updated to include Guangdong and Zhejiang as study sites. The HHS Vulnerability Disclosure link in the footer has been removed.
    Difference
    0.3%
    Check dated 2025-12-23T21:16:26.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.